2021-10-19
- The School of Molecular & Cellular Biology partnered with the eClose Institute to offer a new program for middle and high school students from historically excluded groups that introduces them to scientific research opportunities.
2021-10-15 - From helping bring a powerful, first-in-class HIV treatment to market to his most recent position as the CEO and co-owner of a preclinical contract research organization, Michael Recny (PhD, biochemistry, ’83) has paved a successful career path in the biotechnology industry, a field that was just emerging at the time he graduated from the University of Illinois.
2021-10-11 - The School of Molecular & Cellular Biology and Department of Cell & Developmental Biology are thrilled to welcome new faculty member Kevin Van Bortle! He joins us from the Stanford University School of Medicine, where he conducted his postdoctoral research. We recently spoke with him about his research and teaching interests, what drew him to the University of Illinois, and how he spends...
2021-10-05 - Nicholas Wu, a professor of biochemistry at the University of Illinois Urbana-Champaign, has received a National Institutes of Health Director’s New Innovator Award, part of the Common Fund’s High-Risk, High-Reward Research program.
2021-09-30 - Researchers at the University of Illinois Urbana-Champaign can now rapidly isolate and chemically characterize individual organelles within cells. The new technique tests the limits of analytical chemistry and rapidly reveals the chemical composition of organelles that control biological growth, development and disease.
2021-09-20 - People infected with the original strain of the virus that causes COVID-19 early in the pandemic produced a consistent antibody response, making two main groups of antibodies to bind to the spike protein on the virus’s outer surface. However, those antibodies don’t bind well to newer variants, a new study from the University of Illinois Urbana-Champaign found.
2021-09-15 - Albert Feng, a passionate and beloved scholar who studied the neural basis of sound communication, has passed away.
2021-08-31 - In a new University of Illinois study, researchers found that genes encoding a previously unstudied family of RBPs are highly expressed in many Bacteroides species. They also demonstrated that mutants of the prevalent human gut bacteria Bacteroides thetaiotaomicron that lacked RBPs exhibited changes in polysaccharide utilization.
2021-08-24 - University of Illinois President Tim Killeen on Monday honored 28 key leaders of the system’s COVID-19 response with the Presidential Medallion. The medallion is the highest honor that the system president can bestow.
2021-08-17 - Blue light is illuminating new understanding of a key signaling pathway in embryo development, tissue maintenance, and cancer genesis.
2021-08-17 - Phospholipid-protein interactions play an essential role in the regulation of many important cellular processes. The largest family of putative lipid-binding proteins contain the pleckstrin homology (PH) domain. Previous studies in the field estimate that approximately 10 percent of the PH protein family binds to phosphatidylinositol phosphate (PIP) with high specificity and affinity. However,...
2021-08-16 - The Department of Molecular & Integrative Physiology in the School of Molecular & Cellular Biology is pleased to welcome new faculty member Patrick Sweeney!
2021-08-11 - Congratulations to the Tajkhorshid lab and collaborators who created a stunning research image recently highlighted by the National Institutes of Health.
2021-08-03 - Researchers report that infantile spasms, a rare but serious seizure disorder in babies, appear to be the result of a molecular pathway gone awry. In their study of a mouse model of the disorder, the researchers discovered that genetic mutations associated with the disease impair a pathway that is involved in building new synapses in the hippocampus, a brain region essential to learning and...
2021-07-20 - A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels.